PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ProShares Ultra Nasdaq Biotechnology (BIB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS74347R2141
CUSIP74347R214
IssuerProShares
Inception DateApr 7, 2010
RegionNorth America (U.S.)
CategoryLeveraged Equities, Leveraged
Leveraged2x
Index TrackedNASDAQ Biotechnology Index (200%)
Home Pagewww.proshares.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

The ProShares Ultra Nasdaq Biotechnology has a high expense ratio of 0.95%, indicating higher-than-average management fees.


0.50%1.00%1.50%2.00%0.95%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIB

ProShares Ultra Nasdaq Biotechnology

Popular comparisons: BIB vs. XBI, BIB vs. BIS, BIB vs. IBBQ, BIB vs. ARKG, BIB vs. BBH, BIB vs. SPY, BIB vs. AMGN, BIB vs. LABU

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ProShares Ultra Nasdaq Biotechnology, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%300.00%400.00%500.00%600.00%700.00%OctoberNovemberDecember2024FebruaryMarch
676.06%
342.37%
BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)

S&P 500

Returns By Period

ProShares Ultra Nasdaq Biotechnology had a return of 1.90% year-to-date (YTD) and 11.38% in the last 12 months. Over the past 10 years, ProShares Ultra Nasdaq Biotechnology had an annualized return of 4.44%, while the S&P 500 had an annualized return of 10.96%, indicating that ProShares Ultra Nasdaq Biotechnology did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date1.90%10.04%
1 month-4.10%3.53%
6 months19.43%22.79%
1 year11.38%32.16%
5 years (annualized)0.96%13.15%
10 years (annualized)4.44%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20240.11%1.21%
2023-1.25%-8.35%-13.34%9.12%25.86%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
BIB
ProShares Ultra Nasdaq Biotechnology
0.35
^GSPC
S&P 500
2.76

Sharpe Ratio

The current ProShares Ultra Nasdaq Biotechnology Sharpe ratio is 0.35. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
0.35
2.76
BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)

Dividends

Dividend History

ProShares Ultra Nasdaq Biotechnology granted a 0.14% dividend yield in the last twelve months. The annual payout for that period amounted to $0.08 per share.


PeriodTTM20232022
Dividend$0.08$0.04$0.02

Dividend yield

0.14%0.07%0.03%

Monthly Dividends

The table displays the monthly dividend distributions for ProShares Ultra Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.04
2022$0.02

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-47.81%
0
BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ProShares Ultra Nasdaq Biotechnology. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ProShares Ultra Nasdaq Biotechnology was 67.24%, occurring on Jun 27, 2016. Recovery took 1152 trading sessions.

The current ProShares Ultra Nasdaq Biotechnology drawdown is 47.81%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-67.24%Jul 21, 2015237Jun 27, 20161152Jan 25, 20211389
-64.76%Feb 9, 2021339Jun 13, 2022
-41.45%May 13, 201160Aug 8, 2011112Jan 18, 2012172
-39.01%Feb 26, 201433Apr 11, 2014114Sep 24, 2014147
-36.3%Apr 16, 201048Jul 1, 201093Dec 17, 2010141

Volatility

Volatility Chart

The current ProShares Ultra Nasdaq Biotechnology volatility is 9.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%OctoberNovemberDecember2024FebruaryMarch
9.64%
2.82%
BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)